|Year : 2019 | Volume
| Issue : 2 | Page : 96-102
|Effectiveness of adjuvant yoga therapy in diabetic lung: A randomized control trial
Rajasekar Balaji1, Meena Ramanathan2, Ananda Balayogi Bhavanani2, Pajanivel Ranganadin3, Karthik Balachandran4
1 Centre for Yogic Sciences, Aarupadai Veedu Medical College and Hospital, Vinayaka Mission's Research Foundation, Puducherry, India
2 Centre for Yoga Therapy, Education and Research, Sri Balaji Vidyapeeth, Pillaiyarkuppam, Puducherry, India
3 Department of Pulmonary Medicine, MGMCRI, Sri Balaji Vidyapeeth, Pillaiyarkuppam, Puducherry, India
4 Department of Endocrinology, MGMCRI, Sri Balaji Vidyapeeth, Pillaiyarkuppam, Puducherry, India
Click here for correspondence address and email
|Date of Web Publication||6-May-2019|
| Abstract|| |
Context: Recent studies provide ample evidence of the benefits of yoga in various chronic disorders. Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia and Sandler coined the term “Diabetic Lung” for the abnormal pulmonary function detected in diabetic patients due underlying pulmonary dysfunction. Yoga therapy may help in achieving better pulmonary function along with enhanced glycaemic control and overall health benefits. Aim: To study the effect of adjuvant yoga therapy in diabetic lung through spirometry. Settings and Design: Randomized control trial was made as interdisciplinary collaborative work between departments of Yoga Therapy, Pulmonary Medicine and Endocrinology, of MGMC & RI, Sri Balaji Vidyapeeth Puducherry. Materials and Methods: 72 patients of diabetic lung as confirmed by spirometry (<70% of expected) were randomized into control group (n=36) who received only standard medical treatment and yoga group (n=36) who received yoga training thrice weekly for 4 months along with standard medical management. Yoga therapy protocol included yogic counseling, preparatory practices, Asanas or static postures, Pranayama or breathing techniques and relaxation techniques. Hathenas of the Gitananda Yoga tradition were the main practices used. Spirometry was done at the end of the study period. Data was analyzed by Student's paired and unpaired 't' test as it passed normality. Results: There was a statistically significant (P < 0.05) reduction in weight, and BMI along with a significant (P < 0.01) improvement in pulmonary function (FEV1, FVC) in yoga group as compared to control group where parameters worsened over study period. Conclusion: It is concluded from the present RCT that yoga has a definite role as an adjuvant therapy as it enhances standard medical care and hence is even more significant in routine clinical management of diabetes, improving physical condition and pulmonary function.
Keywords: Diabetic lung, PFT, hathenas, yoga therapy
|How to cite this article:|
Balaji R, Ramanathan M, Bhavanani AB, Ranganadin P, Balachandran K. Effectiveness of adjuvant yoga therapy in diabetic lung: A randomized control trial. Int J Yoga 2019;12:96-102
|How to cite this URL:|
Balaji R, Ramanathan M, Bhavanani AB, Ranganadin P, Balachandran K. Effectiveness of adjuvant yoga therapy in diabetic lung: A randomized control trial. Int J Yoga [serial online] 2019 [cited 2022 Aug 14];12:96-102. Available from: https://www.ijoy.org.in/text.asp?2019/12/2/96/257619
| Introduction|| |
Diabetes mellitus (DM) is a group of metabolic diseases characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Type 2 DM (also known as noninsulin-dependent diabetes) is the most common endocrine and metabolic disorder affecting many organ systems. Its incidence is phenomenally increasing primarily because of increase in the prevalence of a sedentary lifestyle and stress of modern lifestyle and is attributed to the interaction between a genetic predisposition along with behavioral and environmental risk factors. A large number of patients are on lifelong drug therapy imposing a huge economic burden and undesirable side effects of allopathic drugs. It is projected that, by the year 2030, India will have the most number of diabetic patients worldwide. In 2013, about 12% of the world's adult population (~2.85 crore people) had diabetes and 3.16 crore had impaired glucose tolerance. The curve is going on rising among Indians and is expected to reach 7.9 crores by 2030.
The role of yoga in management and treatment of diabetes has been the subject of curiosity in India as well as abroad. It has been reported that a combination of oral hypoglycemic drugs, insulin, and dietary modification along with exercise can help in such patients. Despite treatment, there is a lacuna in control of blood sugar level which leads to hyperglycemia coupled with further complications such as diabetic retinopathy, neuropathy, or nephropathy. Yoga is an ancient, traditional Indian exercise regimen that has been proved to be beneficial in various chronic disorders including asthma, hypertension, psoriasis, arthritis, and diabetes. Skoro-Kondza et al. confirmed a small fall in HbA1c level in yoga group but also stated that it was not sustained due to lack of self-efficacy.
Yoga offers a promising lifestyle intervention for decreasing risk factors related to diabetes by decreasing stress and promoting relaxation as it has been reported to decrease weight related type 2 diabetes risk factors, enhance glycemic control, as well as increase psychological well-being., This has been attributed to various mechanisms including increased metabolism of glucose, facilitation of glycolysis, and increased metabolic rate. The evidence in Complementary and Alternative Medicine (CAM) has built up to an extent that the American Diabetes Association has stated that adjuvant therapies may be utilized in cases of diabetes when based on evidence from randomized controlled trials (RCTs).
Sandler reported that abnormal pulmonary function has been detected in diabetic patients due to pathogenesis underlying pulmonary dysfunction in such subjects. He suggested the concept that is today referred to as “diabetic lung.” Other studies have studied the association between glycemic state and lung function and reported deterioration in pulmonary function tests (PFT), namely forced expiratory volume in 1st s (FEV1), forced vital capacity (FVC), and FEV1/FVC correlated to deteriorating glycemic control., Sreeja et al. suggested that decreased lung function might be related to poor mechanical properties of lung as lung compliance and elastic recoil of lungs as well as total lung capacity were lower in patients of DM. However, Benbassat et al. concluded that there was no correlation between the PFT and duration of DM, presence of microangiopathy, or glycemic control.
Mohankumar and Arulmozhi studied pulmonary complications in elderly diabetics. They reported that in DM total lung capacity, lung volume, and lung compliance are reduced, the central and peripheral airflows are reduced, and acceleration of aging process in pulmonary connective tissue is seen. There is interference with connective tissue cross-links, presence of increased nonenzymatic glycosylation, and modification of alveolar surfactant action. The diffusing capacity for carbon monoxide is reduced because of pulmonary microangiopathy in DM. A study done in 24 noninsulin-dependent DM patients with 40 days of yoga showed improvements in glycemic control as well as pulmonary function (FEV1, FVC, peak expiratory flow rate, and maximum voluntary ventilation).
Yoga therapy may help in achieving better pulmonary function along with enhanced glycemic control and overall health benefits. Mandanmohan et al. compared the effect of slow and fast pranayama on PFT and concluded that fast pranayama was most effective in improving pulmonary functions.
Hence, it is imperative that adjuvant yoga therapy would improve all study parameters in diabetic lung patients. The importance of this study is that it will pave way for application of yoga therapy in diabetic lung patients and enable determination of prognosis in individuals. As there is a paucity of literature on effects of yoga in diabetic lung, the present study was done to evaluate role of adjuvant yoga therapy in diabetic lung patients.
| Materials and Methods|| |
This study was undertaken as an interdisciplinary collaborative work between the Centre for Yoga Therapy, Education and Research (CYTER) of Sri Balaji Vidyapeeth University and the Departments of Pulmonary Medicine and Endocrinology of MGMCRI, Puducherry. Approval was obtained from Institutional Research Council of MGMCRI and Institutional Human Ethics Committee, Sri Balaji Vidyapeeth University. The study was also registered retrospectively on the Clinical Trial Registry-India (CTRI: 2017/11/010479).
Diabetic patients with lung function <70% of predicted values by spirometry (excluding other comorbidities of lung) who were willing to participate and were able to perform techniques in the protocol were recruited for the study along with informed consent. Those with active infections of lungs, especially pulmonary tuberculosis and evidence of complications of diabetes and lungs, were excluded from the study.
A total of 100 diabetic lung patients were assessed for eligibility. Out of them, 72 patients (mean age: 49.6 ± 5.88 years) satisfied that the inclusion criteria were randomized to yoga group (who received yoga therapy training at CYTER thrice weekly for 4 months along with standard medical management with advice on diet) and control group (on standard medical management with advice on diet). Mean age of yoga group (22 males and 12 females) was 51.85 ± 7.60 years while that of control group (25 males and 10 females) was 49.6 ± 5.88 years.
All participants were motivated to do practices at home and maintain a diary to evaluate compliance. Patients were followed up rigorously by weekly telephonic conversations. Thirty-four patients in the yoga group completed the study (two dropped out for personal reasons) and 35 in the control group with one dropout.
Standard medical care for all subjects was provided through the outpatient department of general medicine and pulmonary medicine, and medications included oral hypoglycemic drugs (sulfonylureas/biguanides/glitazones) or insulin for glycemic control was given.
Yoga therapy sessions were conducted at CYTER [Table 1] by trained and qualified yoga therapists. Components of yoga therapy protocol included yogic counseling, preparatory practices, brahma mudra, chandra nadi, and bhramari pranayamas, shavasana relaxation, and a series of 15 asanas, mudras, and pranayamas collectively known as Hathenas in the Gitananda (Rishiculture Ashtanga) Yoga tradition. All of these are traditional yoga practices that enhance awareness and mindfulness of the various lung segments, thus facilitating flow of prana into those regions [Figure 1].
|Table 1: Yoga practices (given thrice a week for 4 months) and their duration|
Click here to view
|Figure 1: Hathenas: a series of 15 techniques of Gitananda Yoga tradition designed to consciously enhance flow of prana into different parts of the lungs|
Click here to view
Hathenas to increase breath capacity and efficiency in the low chest area (adham pranayama) are based on ushthra asana, the camel pose, and help expand and stretch tissue in the lower lung region. They recondition the respiratory system to perform conscious and efficient low-chest breathing known as adham pranayama. The techniques include sapurna ushthra asana (variation 1 and 2), purna ushthra asana, and sapurna shasha asana. Hathenas to increase breath capacity and efficiency in the middle chest area (madhyam pranayama) are based on matsya asana (the fish posture), and pranic energy is stimulated to flow into the mid chest area, thus strengthening and reconditioning intercostal muscles and lung tissue of this region. The techniques include sapurna and ardha matsya asana, matsya asana, and purna shasha asana. Hathenas to increase breath capacity and efficiency in the upper chest area (adhyam pranayama) include sapurna and purna maha mudra, bala asana, and paripurna shasha asana. To enhance deep, conscious, and controlled breathing into all sections of the lungs (mahat yoga pranayama), Hathenas performed from the four-footed chatus pada asana include the sharabha asana, chiri kriya, and vyagraha pranayama.
Parameters were recorded in all the subjects before and after 4-month study period to assess efficacy of yoga therapy.
Data were collected in the yoga hall of CYTER by the auxiliary nursing midwife (ANM). Individual height was measured to the nearest millimeter by the wall-mounted stadiometer and weight measured with a weighing scale (Krups scale). Body mass index (BMI) was calculated by Quetelet's index, which is weight (kg)/height (m)2 [Table 2].
|Table 2: Comparison of pre, post, delta, and delta% of height, weight, body mass index, forced expiratory volume in 1st s, forced vital capacity, and their ratio (forced expiratory volume in 1st s/forced vital capacity) in yoga and control groups before and after 4 months' study period|
Click here to view
Pulmonary function tests
EASYONE Spirometer (JK Medical Systems Pvt. Ltd., New Delhi) was used for all PFTs. Tests were done by a qualified technician in an approved laboratory. Subject was seated comfortably in upright position with an erect spine, without bending forward. They were then instructed to take the disposable mouthpiece inside their mouth with lips closed over it to avoid leakage of air while blowing. Nose clip was applied during entire maneuver. Test maneuver was repeated thrice with gap of 3–5 min between each maneuver, and the subject was encouraged to perform at their optimum level applying maximal effort. The best maneuver was considered for analysis.
Changes in all parameters were correlated with compliance to yoga therapy, and correlation of changes in physiological and biochemical parameters with changes in lung function was assessed [Table 2].
All data passed normality testing by Kolmogorov–Smirnov test, and hence, intragroup comparisons of pre- and poststudy data were done using Student's paired t-test while intergroup comparisons between groups were done using Student's unpaired t-test. P < 0.05 was considered to indicate significant differences between the means.
| Results|| |
The results are given in [Table 2] and the delta% changes in FEV1, FVC, and FEV1/FVC are shown in [Figure 2], [Figure 3], [Figure 4]. There was a statistically significant (P < 0.05) reduction in weight and BMI in yoga group after 4-month study period. There was significant improvement (P < 0.05) in pulmonary function (FEV1 and FVC) in patients receiving adjuvant yoga therapy.
|Figure 2: Scatter diagram comparing delta% of forced expiratory volume in 1st s between yoga and control groups|
Click here to view
|Figure 3: Scatter diagram comparing delta% of forced vital capacity between yoga and control groups|
Click here to view
|Figure 4: Scatter diagram comparing delta% of forced expiratory volume in 1st s/forced vital capacity between yoga and control groups|
Click here to view
In the yoga group, FEV1 and FVC showed improvement after the 4-month study period (P < 0.001). The FEV1/FVC ratio showed no statistically significant change though there was a slight increase in the post values.
In the control group, FEV1 showed slight increase in the postvalues, which was not statistically significant, whereas FVC increased significantly (P < 0.05) due to which there was a corresponding decrease in the FEV1/FVC ratio also (P < 0.05).
Comparison between the groups, showed statistical significance in FEV1 and FVC (P = 0.003 and 0.016, respectively). The delta% values of FEV1, FVC, and FEV1/FVC ratio between the yoga and control groups showed significance (<0.001, 0.022, and 0.062, respectively).
| Discussion|| |
The present study was planned since there is surge of emerging evidence that yoga as an adjuvant therapy can have significant beneficial effects in diabetic patients. In diabetic patients, lungs are affected by the nonenzymatic glycosylation and this alters the lung connective tissue leading to pulmonary fibrosis and dysfunction. The important aspect of disease-modifying treatment is to have good glycemic control. To the best of our knowledge, this study is the first one of its kinds to assess the impact of yoga as an adjuvant therapy and lifestyle intervention for the derangement of anthropometric indices (height, weight, and BMI) and improvement of pulmonary function (FVC, FEV1, and FEV1/FVC).
Both the yoga and control groups were comparable at baseline with respect to characteristics such as anthropometric parameters and pulmonary functions.
Effect of yoga therapy on anthropometric data
Weight and BMI showed significant decrease in yoga group and marginal increase in the control group. Intergroup comparison of the delta changes and delta% changes shows the difference between the pre- and postvalues in yoga and control groups for weight and BMI that had statistically significant difference, which may be attributed to the practices utilizing excess fat deposited peripherally. This finding is in line with findings of other studies attributing such changes to improved metabolic function and generalized toning up of musculoskeletal system.,,, Some of the practices involving twisting and compression-relaxation actions may be stimulating intra-abdominal organs such as liver and pancreas producing benefits in lipid metabolism.
Yoga has a great potential in preventing and managing chronic diseases and yogic lifestyle can make an appreciable contribution to improvement of health of our masses. Bhavanani stated that yoga has the potential to prevent progression of disease and if started early, maybe even cure it. With multiple collateral benefits and no side effects, yoga can be practiced by ill, elderly, or disabled individuals. It has been suggested that being safe, simple, and economical therapy, yoga should be considered as a beneficial adjuvant for patients of diabetes.
Effect of yoga therapy on pulmonary function
Scientific basis of using yoga as an adjunct therapy in various respiratory disorders such as chronic obstructive pulmonary disease is well established with improvements in lung function, quality of life indices, and bronchial provocation responses coupled with decreased need for regular and rescue medicinal usage.,
However, few studies have assessed the effects of yoga therapy on pulmonary functions in patients of diabetes that reported decline in lung parameters, which were attributed to nonenzymatic glycosylation that altered lung connective tissue and led to pulmonary fibrosis and dysfunction.
One of the newer mechanisms postulated for the benefit yoga is that its practices induce a cyclic loading and unloading of body tissues, thus helping maintain health of the extracellular matrix (ECM) that is made up of various proteins, water, and glycosaminoglycans including hyaluronic acid. It has been suggested that yogic practices may be able to temporarily transform the gel-like ground substances of the ECM into a fluid state, thus helping cells, nutrients, and other components of the matrix to move about freely while removing toxins and waste products through the blood or lymphatic system. Physical techniques of yoga as done in this study may induce optimal levels of compression in the ECM and thus help maintain the number and function of fibroblasts which keep the matrix hydrated, open, and strong.
In this study, we found that patients who received adjuvant yoga therapy showed significant improvements in FEV1 and FVC. FEV1/FVC ratio showed appreciable improvement though it was not statistically significant. We also found positive improvement in control group in FVC because of which FEV1/FVC ratio decreased significantly.
Intergroup comparison of the delta and delta% changes showed greater improvement in yoga group in FEV1 and FVC between groups which may be attributed to nonspecific bronchoprotective or bronchorelaxing effect as reported by Singh et al. who also postulated that pranayama and yoga postures may be used to increase respiratory stamina, relax chest muscles, expand lungs, raise energy levels, and calm the body.
Tandon observed improved exercise tolerance following yoga therapy in patients of chronic severe airway obstruction. Bernardi et al. reported that slow yogic breathing maintained better blood oxygenation without increasing minute ventilation and also found reduced sympathetic activation during altitude-induced hypoxia.
Improvement of all lung function parameters in yoga group may be attributed to the regular practice of the Hathenas that are specialized yoga techniques aimed at increasing respiratory muscle stamina, lung expansion as well as conscious breath work to relax respiratory process improving lung elasticity and compliance. Pulmonary functions in diabetes patients are usually compromised. Yoga has improved these by various mechanisms which include reduction of obesity, increased oxygenation, opening of airspaces, and recruitment of alveoli. Our results are collaborated by earlier studies reporting similar changes after yoga training in healthy volunteers as well as in those suffering from different conditions.,
| Conclusions|| |
We conclude from the present RCT that yoga has a definite role as an adjuvant therapy along with modern medical management of diabetes. It helps in reduction of weight and BMI which may have an overall beneficial role. Adjuvant yoga therapy induced improvement in lung function clinical parameters including FEV1 and FVC. As compared to control group who received only medical management, yoga group was found to have statistically significant positive effects in all parameters. As many of these parameters worsened in control group over the study period, addition of yoga as an adjuvant therapy may be said to even be enhancing standard medical care and hence is even more significant in routine clinical management of diabetes.
The results of this RCT provide preliminary evidence that addition of yoga as an adjuvant therapy to a standard medical care can provide additional benefit in terms of improving physical condition as well as pulmonary function. Yoga as a therapy is also cost-effective, relatively simple, and carries minimal risk and hence should be advocated as an adjunct, complementary therapy in our search for an integrated system of medicine capable of producing health and well-being for all. It is expected that the results of this RCT will provide impetus for further in-depth research in evaluating the efficacy of yoga as a complimentary therapy in diabetic patients with special reference to diabetic lung.
Support of the benevolent management and visionary administrators of Sri Balaji Vidyapeeth University who setup CYTER in 2010 is gratefully acknowledged. Heartfelt gratitude is offered to Ammaji Yogacharini Meenakshi Devi Bhavanani, Director ICYER, Prof. Dr. Madanmohan, Honorary Advisor CYTER, Dr. Mathan Raj, Assistant professor, Department of Chest and Tuberculosis, Aarupadai Veedu Medical College and Hospital, and Dr. G. Ezhumalai, Senior statistician and Research consultant, SBV, for their constant support, encouragement, and professional advice. We thank Dayanidy G, Lecturer, Dhanushapnadeesh and Sarulatha G, Yoga Instructors, and Ms. Gayathri, ANM, of CYTER for their valuable assistance during the study.
Financial support and sponsorship
Although the present work did not receive any special funding, Sri Balaji Vidyapeeth funds the CYTER and all of its activities in yoga therapy, education, and research.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kharroubi AT, Darwish HM. Diabetes mellitus: The epidemic of the century. World J Diabetes 2015;6:850-67.
Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: A global systematic review. Pharmacoeconomics 2015;33:811-31.
Ginter E, Simko V. Global prevalence and future of diabetes mellitus. Adv Exp Med Biol 2012;771:35-41.
Kaplan-Mayer G. Get moving with yoga. Diabetes Self Manag 2003;20:28, 31-3.
Nyenwe EA, Jerkins TW, Umpierrez GE, Kitabchi AE. Management of type 2 diabetes: Evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 2011;60:1-23.
Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993;328:1676-85.
Desveaux L, Lee A, Goldstein R, Brooks D. Yoga in the management of chronic disease: A systematic review and meta-analysis. Med Care 2015;53:653-61.
Skoro-Kondza L, Tai SS, Gadelrab R, Drincevic D, Greenhalgh T. Community based yoga classes for type 2 diabetes: An exploratory randomised controlled trial. BMC Health Serv Res 2009;9:33.
McDermott KA, Rao MR, Nagarathna R, Murphy EJ, Burke A, Nagendra RH, et al
. A yoga intervention for type 2 diabetes risk reduction: A pilot randomized controlled trial. BMC Complement Altern Med 2014;14:212.
Chimkode SM, Kumaran SD, Kanhere VV, Shivanna R. Effect of yoga on blood glucose levels in patients with type 2 diabetes mellitus. J Clin Diagn Res 2015;9:CC01-3.
Wilson T, Kelly KL, Baker SE. Review: Can yoga breathing exercises improve glycemic response and insulin sensitivity? J Yoga Phys Ther 2017;7:270.
Franz MJ, Bantle JM. American Diabetes Association position statement: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. J Am Diabetes Assoc 2002;102:109-18.
Sandler M. Is the lung a 'target organ' in diabetes mellitus? Arch Intern Med 1990;150:1385-8.
Walter RE, Beiser A, Givelber RJ, O'Connor GT, Gottlieb DJ. Association between glycemic state and lung function: The Framingham heart study. Am J Respir Crit Care Med 2003;167:911-6.
Davis WA, Knuiman M, Kendall P, Grange V, Davis TM; Fremantle Diabetes Study. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: The Fremantle diabetes study. Diabetes Care 2004;27:752-7.
Sreeja CK, Samuel K, Kesavachandran C. Pulmonary function in patient with diabetes mellitus. Indian J Physiol Pharmacol 2003;47:87-93.
Benbassat CA, Stern E, Kramer M, Lebzelter J, Blum I, Fink G, et al
. Pulmonary function in patients with diabetes mellitus. Am J Med Sci 2001;322:127-32.
Kumar M, Arulmozhi S. Diabetes in Elderly: Pulmonary Complication in Elderly Diabetics. Bangalore: Micro Labs Ltd.; 2005. p. 119-25.
Malhotra V, Singh S, Singh KP, Gupta P, Sharma SB, Madhu SV, et al
. Study of yoga asanas in assessment of pulmonary function in NIDDM patients. Indian J Physiol Pharmacol 2002;46:313-20.
Sharma KK, Udayakumara K, Prasada TH, Ajithesha NH. Effect of yoga therapy on lung functions in respiratory disorder subjects. Eur Sci J 2014;10:102-8.
Madanmohan T, Jatiya L, Udupa K, Bhavanani AB. Effect of yoga training on handgrip, respiratory pressures and pulmonary function. Indian J Physiol Pharmacol 2003;47:387-92.
Bhavanani AB. Correction of Breathing Disorders through Rishiculture Ashtanga Yoga. Pondicherry, India: Dhivyananda Creations; 2006.
Madanmohan T, Bhavanani AB, Dayanidy G, Sanjay Z, Basavaraddi IV. Effect of yoga therapy on reaction time, biochemical parameters and wellness score of peri and post-menopausal diabetic patients. Int J Yoga 2012;5:10-5.
Walker M, Meekins G, Hu SC. Yoga neuropathy. A snoozer. Neurologist 2005;11:176-8.
Divekar M, Bhat M, Mulla A. Effect of yoga therapy in diabetes and obesity. J Diabetes Assoc India 1978;17:75-8.
Jain SC, Uppal A, Bhatnagar SO, Talukdar B. A study of response pattern of non-insulin dependent diabetics to yoga therapy. Diabetes Res Clin Pract 1993;19:69-74.
Bhavanani AB. Yoga Chikitsa: The Application of Yoga as a Therapy. Pondicherry, India: Dhivyananda Creations; 2013.
Innes KE, Vincent HK. The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: A systematic review. Evid Based Complement Alternat Med 2007;4:469-86.
Nagarathna R, Nagendra HR. Yoga for bronchial asthma: A controlled study. Br Med J (Clin Res Ed) 1985;291:1077-9.
Vempati R, Bijlani RL, Deepak KK. The efficacy of a comprehensive lifestyle modification programme based on yoga in the management of bronchial asthma: A randomized controlled trial. BMC Pulm Med 2009;9:37.
Uz-Zaman S, Joyshree B, Anilabaran S. Assessment of lung function by spirometry and diffusion studies and effect of glycemic control on pulmonary function in type II diabetes mellitus patient of the Eastern India. J Clin Diagn Res 2014;8:1-4.
Agarwal AS, Fuladi AB, Mishra G, Tayade BO. Spirometry and diffusion studies in patients with type-2 diabetes mellitus and their association with microvascular complications. Indian J Chest Dis Allied Sci 2010;52:213-6.
Singh S, Soni R, Singh KP, Tandon OP. Effect of yoga practices on pulmonary function tests including transfer factor of lung for carbon monoxide (TLCO) in asthma patients. Indian J Physiol Pharmacol 2012;56:63-8.
Tandon MK. Adjunct treatment with yoga in chronic severe airways obstruction. Thorax 1978;33:514-7.
Bernardi L, Passino C, Wilmerding V, Dallam GM, Parker DL, Robergs RA, et al
. Breathing patterns and cardiovascular autonomic modulation during hypoxia induced by simulated altitude. J Hypertens 2001;19:947-58.
Bhavanani AB, Sanjay Z. The role of yoga in managing bronchitis. Clinical Roundup: Selected Treatment Options for Bronchitis. Altern Complement Ther 2011:349-53.
Rodrigues MR, Carvalho CR, Santaella DF, Lorenzi-Filho G, Marie SK. Effects of yoga breathing exercises on pulmonary function in patients with Duchenne muscular dystrophy: An exploratory analysis. J Bras Pneumol 2014;40:128-33.
Ananda Balayogi Bhavanani
Centre for Yoga Therapy, Education and Research, Sri Balaji Vidyapeeth, Pillaiyarkuppam - 607 403, Puducherry
Source of Support: None, Conflict of Interest: None
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2]
|This article has been cited by|
||The Effect of Yoga on Health-Related Fitness among Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
| ||Rakhmat Ari Wibowo, Riskah Nurámalia, Herlin Ajeng Nurrahma, Eva Oktariani, Jajar Setiawan, Ajeng Viska Icanervilia, Denny Agustiningsih |
| ||International Journal of Environmental Research and Public Health. 2022; 19(7): 4199 |
|[Pubmed] | [DOI]|
||Role of yoga as an adjuvant therapy in the management of metabolic syndrome – A randomized control pilot study
| ||Rajasekaran Balaji, Meena Ramanathan, AnandaBalayogi Bhavanani |
| ||Yoga Mimamsa. 2021; 53(2): 116 |
|[Pubmed] | [DOI]|
||Yoga may Prevent Cytokine Storm in COVID-19
| ||Surabhi Gautam, Rima Dada |
| ||Coronaviruses. 2021; 2(3): 284 |
|[Pubmed] | [DOI]|
| Article Access Statistics|
| Viewed||4505 |
| Printed||182 |
| Emailed||0 |
| PDF Downloaded||146 |
| Comments ||[Add] |
| Cited by others ||3 |